Talis Biomedical Corporation (TLIS)

USD 1.6

(6.67%)

Net Income Summary of Talis Biomedical Corporation

  • Talis Biomedical Corporation's latest annual net income in 2023 was -62 Million USD , up 44.08% from previous year.
  • Talis Biomedical Corporation's latest quarterly net income in 2024 Q2 was -8.84 Million USD , up 32.11% from previous quarter.
  • Talis Biomedical Corporation reported an annual net income of -110.88 Million USD in 2022, up 41.78% from previous year.
  • Talis Biomedical Corporation reported an annual net income of -190.45 Million USD in 2021, down -109.12% from previous year.
  • Talis Biomedical Corporation reported a quarterly net income of -8.84 Million USD for 2024 Q2, up 32.11% from previous quarter.
  • Talis Biomedical Corporation reported a quarterly net income of -13.46 Million USD for 2023 Q4, up 14.17% from previous quarter.

Annual Net Income Chart of Talis Biomedical Corporation (2023 - 2018)

Historical Annual Net Income of Talis Biomedical Corporation (2023 - 2018)

Year Net Income Net Income Growth
2023 -62 Million USD 44.08%
2022 -110.88 Million USD 41.78%
2021 -190.45 Million USD -109.12%
2020 -91.07 Million USD -232.01%
2019 -27.43 Million USD -28.57%
2018 -21.33 Million USD 0.0%

Peer Net Income Comparison of Talis Biomedical Corporation

Name Net Income Net Income Difference
Acutus Medical, Inc. -81.66 Million USD 24.07%
Biotricity, Inc. -14.09 Million USD -339.944%
Cell MedX Corp. -142.48 Thousand USD -43417.96%
Dynatronics Corporation -2.69 Million USD -2198.497%
Nemaura Medical Inc. -14.14 Million USD -338.406%
PetVivo Holdings, Inc. -10.95 Million USD -466.0%
RetinalGenix Technologies Inc. -2.09 Million USD -2865.581%
Sonendo, Inc. -60.91 Million USD -1.786%
Telesis Bio, Inc. -47.72 Million USD -29.928%
Viveve Medical, Inc. -22.02 Million USD -181.505%